Congenital Adrenal Hyperplasia clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
Sorry, in progress, not accepting new patients
This is a Phase 3 study to evaluate the efficacy, safety, and tolerability of crinecerfont versus placebo administered for 24 weeks in approximately 165 adult participants with classic CAH due to 21-hydroxylase deficiency. The study consists of a…
San Francisco, California and other locations
Last updated: